Loïc Foulon

Title: **Loïc Foulon: Innovative Mind from Paris**

Introduction

Loïc Foulon is an accomplished inventor based in Paris, France. With a robust portfolio of two patents, he has made notable contributions to the field of pharmaceutical chemistry, focusing on compounds with therapeutic applications.

Latest Patents

Foulon's recent inventions include two significant patents:

1. **3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof**. This invention relates to novel derivatives that exhibit strong affinity and high selectivity for human arginine-vasopressin (AVP) V-receptors. The compounds described in this patent promise potential therapeutic applications due to their unique characteristics.

2. **Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof**. This patent focuses on indolin-2-one pyridine compounds and their pharmaceutically acceptable salts. It also details pharmaceutical compositions and methods for utilizing these compounds in therapeutic settings.

Career Highlights

Loïc Foulon has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His roles within these organizations have allowed him to leverage his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Foulon has collaborated with notable colleagues such as Claudine Serradeil-Le Gal and Gérard Valette. These partnerships have contributed to the successful development of his patented compounds and enriched the collaborative efforts in the research community.

Conclusion

Loïc Foulon exemplifies the spirit of innovation in the pharmaceutical industry. With his recent patents and collaborations, he continues to push the boundaries of therapeutic chemistry, paving the way for advancements that can potentially improve health outcomes. His work not only highlights his inventive prowess but also marks a significant contribution to the field.